financetom
Business
financetom
/
Business
/
Lucid launches cheaper variant of Gravity electric SUV to broaden appeal
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Lucid launches cheaper variant of Gravity electric SUV to broaden appeal
Nov 20, 2025 12:58 PM

(Reuters) -Lucid Group ( LCID ) on Thursday launched a cheaper variant of its Gravity SUV with a starting price of $79,900, as the luxury electric-vehicle maker seeks to reach a broader audience amid slowing EV sales in United States.

The Gravity Touring, offers up to 337 miles of range and seats seven, joining the higher-priced Grand Touring variant in Lucid's SUV lineup.

Orders for the new variant were open on Thursday with some configurations available for immediate delivery.

The model is part of the company's effort to expand beyond its flagship Air sedan and drive volumes amid waning U.S. EV demand after a $7,500 federal tax credit expired at the end of September.

Lucid in the third quarter reported revenue of $336.6 million that missed estimates and cut its full-year production forecast to about 18,000 units, as supply-chain constraints affect production of the Gravity SUV.

The company, like several automakers, has been grappling with a chip shortage, disrupted supplies of rare earth materials, and fallout from a September fire at one of its aluminum suppliers.

EV makers from Tesla to Rivian have warned of softening demand as the expiry of federal incentives weighs on sales.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Delaware Judge Dismisses Complaint Against Meta Platforms
Delaware Judge Dismisses Complaint Against Meta Platforms
Apr 30, 2024
02:38 PM EDT, 04/30/2024 (MT Newswires) -- Meta Platforms ( META ) won a victory Tuesday in the Delaware Court of Chancery when Vice Chancellor J. Travis Laster dismissed a complaint from a shareholder activist that claimed that the company's pursuit of profits jeopardized public safety, social well-being, and its stockholders' diversified portfolios. The complaint failed to make a compelling...
Medifast Shares Drop as Q1 Adjusted Earnings, Revenue Decline; Sets Q2 Guidance
Medifast Shares Drop as Q1 Adjusted Earnings, Revenue Decline; Sets Q2 Guidance
Apr 30, 2024
02:31 PM EDT, 04/30/2024 (MT Newswires) -- Medifast ( MED ) shares were more than 18% in recent trading on Tuesday, a day after the company's Q1 adjusted earnings miss consensus. The company reported Q1 adjusted earnings Monday of $0.66 per diluted share, down from $3.67 a year earlier. Analysts polled by Capital IQ expected $0.80 per share. Revenue for...
Cannabis Stocks Rise on Media Report of DEA Reclassifying Marijuana as Less Dangerous Drug
Cannabis Stocks Rise on Media Report of DEA Reclassifying Marijuana as Less Dangerous Drug
Apr 30, 2024
02:42 PM EDT, 04/30/2024 (MT Newswires) -- Cannabis stocks were up in trading Tuesday after the Associated Press reported that the US Drug Enforcement Administration planned to reclassify marijuana as a drug that posed lesser harm than other substances. The DEA's plan to bump marijuana down to the Schedule III category from its current Schedule I status would require approval...
Top Midday Gainers
Top Midday Gainers
Apr 30, 2024
02:37 PM EDT, 04/30/2024 (MT Newswires) -- Cyclacel Pharmaceuticals ( CYCC ) shares surged more than 47% after the company unveiled Tuesday a private placement of about 5 million shares and warrants, targeting gross proceeds of about $8 million. More than 19.9 million shares traded intraday compared with a daily average of about 109,000. GeneDx ( WGS ) reported late...
Copyright 2023-2026 - www.financetom.com All Rights Reserved